Sarah Burkhead Whittle

Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs

David Steffin, Ibrahim N. Muhsen, LaQuisa Hill et al. · Blood · 2022 · 47 citations · Full text

Subsequent Malignancies, Cell Therapy, Immunology +19

Approval and Perceived Impact of Duty Hour Regulations: Survey of Pediatric Program Directors

Brian C. Drolet, Sarah Burkhead Whittle, Mamoona T. Khokhar et al. · PEDIATRICS · 2013 · 38 citations

Clinical and CT features of benign pneumatosis intestinalis in pediatric hematopoietic stem cell transplant and oncology patients

M. Beth McCarville, Sarah Burkhead Whittle, Geoffrey S. Goodin et al. · Pediatric Radiology · 2008 · 31 citations · Full text

Benign Pneumatosis Intestinalis, Intestinal Transplantation, Gastrointestinal Oncology +7

Congenital spindle cell rhabdomyosarcoma: An international cooperative analysis

Sarah Burkhead Whittle, Rajkumar Venkatramani, Anton Schönstein et al. · European Journal of Cancer · 2022 · 29 citations · Full text

Cell Division, Surgical Pathology, Histopathology +5

Incidence and risk factors of bacterial and fungal infection during induction chemotherapy for high-risk neuroblastoma

Sarah Burkhead Whittle, Kaitlin C. Williamson, Heidi V. Russell · Pediatric Hematology and Oncology · 2017 · 25 citations · Full text